Drug-induced parkinsonism and other movement disorders (Q28331035)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2192787%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

review article

1 reference

title

Drug-induced parkinsonism and other movement disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2192787%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

2 references

1 reference

parkinsonian syndrome

1 reference

R T Ross

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2192787%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

language of work or name

English

0 references

publication date

1 May 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2192787%20AND%20SRC:MED&resulttype=core&format=json

Canadian Journal of Neurological Sciences

25 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2192787%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2192787%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2192787%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

page(s)

155-162

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2192787%20AND%20SRC:MED&resulttype=core&format=json

Extrapyramidal side-effects of metoclopramide

25 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Pseudohypoparathyroidism presenting as severe Parkinsonism

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Parkinsonism associated with intraventricular amphotericin B.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Oral Facial Dyskinesia Associated with Prolonged Use of Antihistaminic Decongestants

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Chorea induced by oral contraceptives

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

The effect of d-amphetamine on choreiform movement disorders

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Methylphenidate-induced chorea: Case report and pharmacologic implications

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Parkinsonian side effects induced by a monoamine oxidase inhibitor

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Deprenyl is a selective inhibitor of brain MAO-B in the long-term treatment of Parkinsons's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

IMIPRAMINE IN TREATMENT OF PARKINSONISM: A DOUBLE-BLIND PLACEBO STUDY

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Case report of tardive dyskinesia and parkinsonism associated with amoxapine therapy.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Adverse reactions suggesting amoxapine-induced dopamine blockade

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Parkinson's disease. Clues to aetiology from a toxin

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Letter: Neurotoxicity of 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Case report of withdrawal dyskinesia associated with amoxapine

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Drug-induced parkinsonism in the elderly

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Parkinson's disease and pesticides

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Parkinsonism provoked by alcoholism

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Transitory procaine-induced Parkinsonism

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

NEUROMUSCULAR EFFECTS OF LONG-TERM PHENOTHIAZINE MEDICATION, ELECTROCONVULSIVE THERAPY AND LEUCOTOMY

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Perhexiline Maleate As a Cause of Reversible Parkinsonism and Peripheral Neuropathy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

MPTP: an industrial chemical and contaminant of illicit narcotics stimulates a new era in research on Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

A danger in making the diagnosis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

In-vivo decarboxylation of alpha-methyl DOPA and alpha-methyl metatyrosine

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Normal MPTP binding in parkinsonian substantial nigra: evidence for extraneuronal toxin conversion in human brain

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Parkinson Disease Treated With a Suspected Dopamine Receptor Agonist

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Prolonged drug-induced Parkinsonism

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Severe parkinsonism in two AIDS patients taking prochlorperazine

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Paraquat and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Carbon disulfide intoxication from overdosage of disulfiram

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Alcohol and Parkinson disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Alcohol and Parkinson disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

The brain-stem lesions in Parkinsonism

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Development of parkinsonism after gradual reduction of fluphenazine dosage

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Pargyline Prevents MPTP-Induced Parkinsonism in Primates

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Low urinary dopamine and prediction of phenothiazine-induced Parkinsonism: a preliminary report

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

https://api.crossref.org/works/10.1017%2FS0317167100030389

1 reference

7 January 2021

Parkinsonism by haloperidol and piribedil

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Methanol poisoning: a clinical and pathological study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Synergistic neurotoxicity of carbon tetrachloride/carbon disulfide (80/20 fumigants) and other pesticides in grain storage workers

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Reversibility of drug-induced parkinsonism.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Progress in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Epidemiology of parkinsonism: Incidence, classification, and mortality

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

The clinical syndrome of striatal dopamine deficiency: parkinsonism induced by MPTP.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Catatonic reactions to high-potency neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

A new series of potent analgesics: dextro 2:2-diphenyl-3-methyl-4-morpholinobutyrylpyrrolidine and related basic amides. II. Comparative analgesic activity, acute toxicity and tolerance development in rats for R875, morphine, pethidine and methadone

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Prolonged Adverse Effects of Haloperidol in Normal Subjects

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Reversible drug-induced parkinsonism. Clinicopathologic study of two cases

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Parkinsonism Syndrome Due to Cephaloridine

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Movement disorders and AIDS

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Long persisting drug-induced parkinsonism--a case report

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Young age parkinsonism and common drugs

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

An electron microscopic study of MPTP-induced inclusion bodies in an old monkey

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Single case study. Possible organophosphate-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Epidemiology of hexachlorobenzene-induced porphyria in Turkey: clinical and laboratory follow-up after 25 years

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Paraquat and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Parkinsonism occurring with methyldopa treatment.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

PARKINSONISM ASSOCIATED WITH ALPHA-METHYLDOPA THERAPY.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Neuroleptic-induced akathisia and dystonia triggered by alcohol

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Parkinsonian syndrome after methanol intoxication

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

Sulfonylurea-induced Hypoglycemia Associated with Unusual Neurological Features

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030389

7 January 2021

10.1017/S0317167100030389

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2192787%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2192787%20AND%20SRC:MED&resulttype=core&format=json